ES2525668T3 - Composición farmacéutica que comprende tramadol y quetoprofeno en asociación - Google Patents

Composición farmacéutica que comprende tramadol y quetoprofeno en asociación Download PDF

Info

Publication number
ES2525668T3
ES2525668T3 ES08700474.3T ES08700474T ES2525668T3 ES 2525668 T3 ES2525668 T3 ES 2525668T3 ES 08700474 T ES08700474 T ES 08700474T ES 2525668 T3 ES2525668 T3 ES 2525668T3
Authority
ES
Spain
Prior art keywords
tramadol
ketoprofen
pharmaceutical composition
association
solvates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08700474.3T
Other languages
English (en)
Inventor
Henry Jun Suzuki
Dante Alário JUNIOR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biolab Sanus Farmaceutica Ltda
Eurofarma Laboratorios Ltda
Original Assignee
Biolab Sanus Farmaceutica Ltda
Eurofarma Laboratorios Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39674529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2525668(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Eurofarma Laboratorios Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Application granted granted Critical
Publication of ES2525668T3 publication Critical patent/ES2525668T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica que consiste de una combinación para la administración oral de: (a) tramadol, sus sales o solvatos en forma de una tableta recubierta, (b) quetoprofeno, sus sales o solvatos en forma de un polvo granulado y, (c) opcionalmente, uno o más excipientes farmacéuticamente aceptables; en una cápsula dura individual; en donde dicho tramadol no está en contacto con quetoprofeno.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6

Claims (1)

  1. imagen1
ES08700474.3T 2007-01-29 2008-01-28 Composición farmacéutica que comprende tramadol y quetoprofeno en asociación Active ES2525668T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0700133-9A BRPI0700133A (pt) 2007-01-29 2007-01-29 composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
BRPI0700133 2007-01-29
PCT/BR2008/000024 WO2008092219A2 (en) 2007-01-29 2008-01-28 Pharmaceutical composition comprising tramadol and ketoprofen

Publications (1)

Publication Number Publication Date
ES2525668T3 true ES2525668T3 (es) 2014-12-29

Family

ID=39674529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08700474.3T Active ES2525668T3 (es) 2007-01-29 2008-01-28 Composición farmacéutica que comprende tramadol y quetoprofeno en asociación

Country Status (13)

Country Link
US (1) US8715726B2 (es)
EP (1) EP2117519B1 (es)
JP (1) JP5441117B2 (es)
AR (1) AR065068A1 (es)
BR (1) BRPI0700133A (es)
CL (1) CL2008000227A1 (es)
CO (1) CO6210807A2 (es)
EC (1) ECSP099596A (es)
ES (1) ES2525668T3 (es)
MX (1) MX2009008108A (es)
PE (1) PE20081637A1 (es)
PT (1) PT2117519E (es)
WO (1) WO2008092219A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353541B1 (es) 2009-07-30 2011-09-20 Farmalider, S.A. Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion.
ES2432222B1 (es) 2012-04-30 2014-06-10 Farmalider S.A. Composición farmacéutica inyectable de dexketoprofeno y tramadol
ITMI20130210A1 (it) 2013-02-14 2014-08-15 Menarini Lab Composizioni farmaceutiche contenenti dexketoprofene e tramadolo
WO2019122982A1 (en) 2017-12-21 2019-06-27 Grünenthal GmbH Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment
MX2018013070A (es) 2017-12-29 2019-10-15 Gruenenthal Gmbh Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor.
WO2022023211A1 (en) 2020-07-31 2022-02-03 Krka, D.D., Novo Mesto Formulation containing dexketoprofen and tramadol and method for making the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
HU229291B1 (en) * 2001-01-31 2013-10-28 Evonik Roehm Gmbh Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
EP1575566B1 (en) * 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
US8263126B2 (en) * 2003-06-06 2012-09-11 Ethypharm Orally-dispersible multilayer tablet
FR2855756B1 (fr) 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
WO2005034859A2 (en) * 2003-10-03 2005-04-21 Elite Laboratories Inc. Extended release formulations of opioids and method of use thereof
AU2006269225B2 (en) * 2005-07-07 2011-10-06 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
MX2008011441A (es) * 2006-03-06 2008-11-18 Pozen Inc Formas de dosificacion para administrar combinaciones de farmacos.

Also Published As

Publication number Publication date
US20100062060A1 (en) 2010-03-11
MX2009008108A (es) 2009-12-14
PE20081637A1 (es) 2008-11-22
EP2117519A2 (en) 2009-11-18
JP2010516789A (ja) 2010-05-20
ECSP099596A (es) 2009-09-29
PT2117519E (pt) 2014-12-18
WO2008092219A2 (en) 2008-08-07
US8715726B2 (en) 2014-05-06
CL2008000227A1 (es) 2008-08-08
WO2008092219A3 (en) 2008-09-25
EP2117519A4 (en) 2011-10-12
CO6210807A2 (es) 2010-10-20
EP2117519B1 (en) 2014-09-10
BRPI0700133A (pt) 2008-09-16
JP5441117B2 (ja) 2014-03-12
AR065068A1 (es) 2009-05-13

Similar Documents

Publication Publication Date Title
ES2582779T3 (es) Forma de dosificación oral de acetaminofeno/tramadol de liberación prolongada
ES2524556T3 (es) Composiciones farmacéuticas
ES2525668T3 (es) Composición farmacéutica que comprende tramadol y quetoprofeno en asociación
ES2545205T3 (es) Combinación de azelastina y ciclesonida
ES2631980T3 (es) Formas de dosificación orales farmacéuticas que comprenden dabigatrán etexilato y sus sales farmacéuticamente aceptables
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2497494T3 (es) Método de tratamiento y prevención del hiperparatiroidismo secundario
ES2524345T3 (es) Composición farmacéutica oral
ES2515168T3 (es) Detección y tratamiento de la esquizofrenia
AR082493A1 (es) Formulaciones a base de nalbufina, y sus utilizaciones
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
CR10349A (es) Tabletas de paracetamol de liberacion rapida
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
ECSP088422A (es) Composiciones farmacéuticas sólidas que contienen pregabalina
DK1789021T4 (da) Forlænget-frigivelse-tabletformulering indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf
BRPI0620863A8 (pt) comprimido em camadas com combinação de liberação tripla
AR079208A2 (es) Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
WO2011101866A3 (en) Gastric retention formulation containing baclofen
ECSP088296A (es) Compuestos terapéuticos
EP4516353A3 (en) Pharmaceutical compositions comprising (2s)-{(1s)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
AR115913A1 (es) Formas de dosificación oral biodisponibles, uso, métodos
CO6150126A2 (es) Formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina
AR092356A1 (es) Formulacion compuesta para administracion oral que comprende metformina y rosuvastatina y metodo de preparacion de la formulacion